Panagene Inc
KOSDAQ:046210
Panagene Inc
Operating Income
Panagene Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Panagene Inc
KOSDAQ:046210
|
Operating Income
-₩1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
6%
|
Celltrion Inc
KRX:068270
|
Operating Income
₩651.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Income
-₩12B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Operating Income
₩117.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Operating Income
₩92.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Operating Income
-₩9.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
See Also
What is Panagene Inc's Operating Income?
Operating Income
-1.8B
KRW
Based on the financial report for Dec 31, 2023, Panagene Inc's Operating Income amounts to -1.8B KRW.
What is Panagene Inc's Operating Income growth rate?
Operating Income CAGR 10Y
6%